Axalta Coating Systems and AkzoNobel Finalize Governance Terms for Combined Entity Following Merger Amendment

Transaction Structure and Timeline

Axalta Coating Systems, a Pennsylvania-based manufacturer of coating and paint systems headquartered in Philadelphia, first entered into its merger agreement with AkzoNobel on November 18, 2025. The transaction is structured as a two-step merger process in which AkzoNobel's subsidiary, Eagles MergeCo Ltd., merges with Axalta, with Axalta continuing as the surviving company. Axalta then merges into a second AkzoNobel subsidiary, Eagles Holding Ltd., which becomes the final surviving entity of the combined organization. This structure enables the integration of AkzoNobel's global coating operations with Axalta's established business divisions and market presence.

The original agreement underwent its first amendment on May 27, 2026, followed by joinder agreements executed on July 13, 2026, through which the two AkzoNobel subsidiaries formally joined the transaction. The most recent amendment, executed on July 23, 2026, represents the third modification to the merger framework and addresses specific governance questions that arose during the negotiation and documentation phase. The company did not disclose a specific completion date for the merger in this announcement, though investors may be watching for updates regarding regulatory approvals and shareholder votes required to finalize the transaction.

Director Election and Governance Framework Modifications

The Second Amendment fundamentally alters the director election process that will govern the combined entity during its initial three-year period following merger completion. Under the modified terms, all directors of the surviving company, referred to as MergeCo, will face annual re-election after the initial three-year period concludes. This provision aligns with market practice at multinational industrial companies and ensures regular accountability to shareholders through periodic director elections. The amendment specifically establishes this as the standard governance procedure that will persist following the initial transition period, providing predictability for shareholders regarding the governance cycle post-completion.

During the critical three-year period immediately following merger completion, the amendment establishes heightened approval requirements for certain governance actions. A two-thirds majority vote of MergeCo's non-executive directors becomes the approval threshold for four categories of significant corporate decisions: any proposal regarding the appointment and dismissal of directors submitted to the general shareholder meeting, the appointment and removal of the Chief Executive Officer, the appointment and removal of the Deputy Chief Executive Officer and Chief Financial Officer, and any amendments to the company's remuneration policy. These requirements create meaningful oversight mechanisms during the integration phase when the combined entity is establishing its operational and cultural alignment.

Executive Leadership and Compensation Policy Governance

The appointment and removal provisions for C-suite executives under the revised governance structure reflect the significance of leadership continuity during the post-merger integration period. The two-thirds non-executive director approval requirement for CEO, Deputy CEO, and CFO appointments ensures that these critical leadership positions receive substantial oversight from independent directors unaffiliated with management. This governance design acknowledges that executive stability and qualified leadership during the transition to a combined entity represents a material concern for both legacy Axalta shareholders and AkzoNobel stakeholders. The amendment also addresses the removal process with the same elevated approval threshold, preventing unilateral executive changes without substantial board consensus.

Remuneration policy modifications similarly require two-thirds non-executive director approval during the initial three-year period. This provision grants independent directors significant control over executive compensation philosophy, structure, and incentive alignment during the period when the combined organization is integrating compensation systems, retirement plans, and incentive programs from two previously independent companies. The elevated threshold reflects recognition that compensation policies carry material business implications and require careful coordination with broader integration objectives. Following the conclusion of the three-year initial period, remuneration policy amendments would presumably revert to standard corporate governance procedures, though the amendment does not explicitly specify this transition.

Non-Executive Director Authority and Board Composition

The elevation of non-executive director authority in the amendment reflects a governance philosophy emphasizing independent board oversight during the critical merger integration period. By granting non-executive directors the specific power to approve director appointments, executive selections, and compensation frameworks through a two-thirds majority vote, the amendment shifts decision-making authority away from potential management conflicts of interest. Non-executive directors, by definition, do not hold operational management positions and therefore bring independent judgment to governance decisions that might otherwise be influenced by management preferences or integration pressures. This structure protects minority shareholders and ensures that board composition decisions reflect shareholder interests rather than management convenience.

The amendment's specific focus on non-executive director authority in approving director appointments and removals creates a mechanism for ongoing board evolution and refreshment following the merger. Rather than lock the board composition in place for the three-year initial period, shareholders retain the ability to shape board composition through general meeting votes that require non-executive director endorsement. This flexibility acknowledges that a three-year integration period may require adjustments to board expertise and skill sets as the combined company identifies operational priorities and strategic initiatives. The provision thus balances stability with adaptability, a critical consideration during significant organizational transitions.

Designation of Board Leadership Positions

The amendment specifically addresses the designation of Chairman and Vice Chairman titles as a governance matter requiring two-thirds non-executive director approval during the initial three-year period. Board leadership roles carry material significance within corporate governance frameworks, as the Chairman and Vice Chairman positions influence board agenda-setting, executive accountability, and shareholder communication. By requiring substantial non-executive director consensus for these designations, the amendment ensures that critical leadership roles cannot be assigned through management preference alone. This provision reflects governance best practices increasingly expected at large multinational companies, where board leadership independence and shareholder alignment receive heightened scrutiny.

The focus on title designation, rather than merely the individuals holding those positions, suggests the amendment contemplates scenarios where board members might hold different leadership roles during the three-year period or where leadership responsibilities might shift following executive appointments or departures. The non-executive director approval requirement provides a governance checkpoint ensuring that board leadership selections remain aligned with broader board composition and strategic oversight objectives. This level of specificity in the amendment demonstrates careful attention to the operational details of board governance during the integration period when board composition and leadership may require adjustment as the combined entity's strategic priorities emerge.

Previous Amendment History and Transaction Continuity

The Second Amendment represents the latest in a series of modifications to the original merger framework, each addressing specific governance and structural questions that emerged during the transaction's development. The original Merger Agreement filed on November 18, 2025, established the fundamental transaction structure and economic terms governing the combination of Axalta and AkzoNobel. The First Amendment, executed on May 27, 2026, modified specific provisions of the original agreement without fundamentally altering the transaction's strategic rationale or overall structure. The Joinder Agreements filed on July 13, 2026, brought AkzoNobel's subsidiary entities formally into the merger framework and established their specific roles within the dual-merger structure.

The Second Amendment represents a refinement of governance mechanisms rather than a restructuring of the underlying transaction. The filing specifically states that except to the extent modified by the Second Amendment, all provisions of the Original Merger Agreement, as previously amended, remain unmodified and in full force and effect. This language preserves continuity with the earlier modifications while establishing new governance parameters that reflect discussions and agreements reached during the subsequent three-month period. The accumulation of amendments through this period suggests ongoing negotiation and refinement of the transaction terms, a pattern common in large cross-border mergers where governance structures must accommodate multiple regulatory jurisdictions and shareholder constituencies.

Joint Announcement and Public Communication

Axalta Coating Systems and AkzoNobel issued a joint press release on July 23, 2026, announcing the governance modifications established through the Second Amendment. The coordination of announcement timing and messaging between the two companies reflects the collaborative nature of the merger process and the parties' interest in communicating unified positions to investors and stakeholders regarding the merged entity's governance framework. Joint announcements of this type typically convey that both parties view the modifications as mutually beneficial and necessary to the transaction's successful completion. The simultaneous disclosure to public markets ensures that both sets of shareholders receive consistent information about the governance arrangements that will govern the combined organization.

The decision to announce the governance modifications through a joint press release rather than through separate company disclosures underscores the significance of the governance matters to both legacy company shareholders. Governance provisions, while less visible than operational details or financial projections, carry material weight for long-term shareholders who will hold interests in the combined company following merger completion. By jointly announcing these arrangements, Axalta and AkzoNobel signal their commitment to transparent communication regarding the transaction's progress and the thoughtful governance structure that will guide the merged entity's operations during its critical initial integration period.

Regulatory Status and Securities Law Compliance

AkzoNobel previously filed a registration statement on Form F-4 with the Securities and Exchange Commission on May 27, 2026, as amended on June 18, 2026. That registration statement included Axalta's proxy statement, which also constitutes a prospectus with respect to the shares that AkzoNobel will issue to Axalta shareholders as consideration for the combination. The registration statement and proxy materials represent the formal disclosure documents through which both AkzoNobel and Axalta provide shareholders with material information necessary to evaluate the proposed transaction and exercise voting rights. The amendment to the merger agreement addressed in this current disclosure involves modifications to governance arrangements rather than economic terms or transaction structure, and would be reflected in any updated proxy materials or regulatory filings required before the transaction proceeds to shareholder votes.

The disclosure notes that decisions regarding the transaction must be made on the basis of information contained in and incorporated by reference into the prospectus with respect to AkzoNobel's share issuance, which was published on June 24, 2026. This statement reiterates that shareholders should rely on formal SEC-registered disclosure documents rather than press releases or other announcement materials when making voting or investment decisions. The amendment's governance provisions would constitute material information for Axalta shareholders evaluating whether to approve the merger, as governance arrangements directly affect shareholder rights and oversight mechanisms in the combined company. Investors should review the formal registration statement and proxy materials to fully understand the governance framework and all transaction terms.

Integration Planning and Shareholder Considerations

The careful attention to governance details in the Second Amendment reflects the complexity involved in integrating two substantial multinational coating systems companies with independent governance histories and shareholder bases. Axalta's legacy as a standalone publicly traded company, combined with AkzoNobel's established governance frameworks and international investor base, created a situation where governance arrangements required specific negotiation and documentation to address the concerns of both constituencies. The two-thirds non-executive director approval threshold for executive appointments and compensation matters represents a compromise position between allowing management flexibility in the integration process and ensuring that major decisions receive substantive board oversight. This governance structure is designed to facilitate integration decision-making while protecting shareholder interests during the transition period.

Investors evaluating the transaction should consider how the governance arrangements will function during the actual integration process. The elevated approval thresholds for executive appointments and compensation modifications may slow certain operational decisions during the integration period, though they create important safeguards against potential conflicts of interest or misalignment between legacy Axalta and AkzoNobel interests. The annual director re-election requirement following the initial three-year period ensures that shareholders will have regular opportunities to evaluate board performance and composition at the combined company. The amendment's governance provisions thus balance integration flexibility with shareholder protection, a critical consideration for the success of the transaction and the long-term value creation for shareholders of both legacy companies.